Business UpdateJun 22, 2026, 08:46 AM
AIM ImmunoTech CEO to Present at Webull Webinar Series
AI Summary
AIM ImmunoTech Inc. announced that its CEO, Thomas Equels, will present at the Webull Corporate Connect Webinar Series on June 24, 2026, from 2:40 PM to 3:00 PM ET. The virtual presentation will provide an update on the immuno-pharma company, which is focused on developing Ampligen® for late-stage pancreatic cancer. This participation aims to engage with investors through Webull's leading digital investment platform, which serves over 27 million registered users.
Key Highlights
- AIM ImmunoTech CEO Thomas Equels will present.
- Presentation is part of the Webull Corporate Connect Webinar Series.
- Scheduled for June 24, 2026, from 2:40 PM to 3:00 PM ET.
- Webull platform serves over 27 million registered users globally.
- AIM ImmunoTech focuses on Ampligen® for pancreatic cancer.
Price Impact
More from AIM